Bruton’s Tyrosine Kinase and SLP-65 Regulate Pre-B Cell Differentiation and the Induction of Ig Light Chain Gene Rearrangement1

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Immunology

• Publication date

  2006-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.176.8.4543PMID 16585544
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The lambda5-VpreB1 locus--a model system for studying gene regulation during early B cell development.

  2005cited by this paper
• The pre-B-cell receptor: selector of fitting immunoglobulin heavy chains for the B-cell repertoire

  2005cited by this paper
• Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity.

  2005cited by this paper
• The λ5–VpreB1 locus—a model system for studying gene regulation during early B cell development

  2005cited by this paper
• The Igκ3′ Enhancer Is Activated by Gradients of Chromatin Accessibility and Protein Association1

  2005influential reference
• The Ig kappa 3' enhancer is activated by gradients of chromatin accessibility and protein association.

  2005cited by this paper
• The pre-BCR checkpoint as a cell-autonomous proliferation switch.

  2004cited by this paper
• Variegated transcriptional activation of the immunoglobulin kappa locus in pre-b cells contributes to the allelic exclusion of light-chain expression.

  2004cited by this paper
• Regulation of activation and recombination of the murine Igκ locus

  2004cited by this paper
• Impaired Receptor Editing in the Primary B Cell Repertoire of BASH-Deficient Mice1

  2004cited by this paper
• Regulation of activation and recombination of the murine Igkappa locus.

  2004cited by this paper
• Bruton's Tyrosine Kinase Is Essential for Human B Cell Tolerance

  2004cited by this paper
• The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion

  2003cited by this paper
• Distinct signaling requirements for Dmu selection, IgH allelic exclusion, pre-B cell transition, and tumor suppression in B cell progenitors.

  2003cited by this paper
• IMMATURE SURFACE IG+ B-CELLS CAN CONTINUE TO REARRANGE KAPPA-L-CHAIN AND LAMBDA-L-CHAIN GENE LOCI IG+ B-CELLS

  2003cited by this paper
• IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development.

  2003cited by this paper
• A small molecule Abl kinase inhibitor induces differentiation of Abelson virus–transformed pre-B cell lines

  2003cited by this paper
• Bruton's Tyrosine Kinase Cooperates with the B Cell Linker Protein SLP-65 as a Tumor Suppressor in Pre-B Cells

  2003influential reference
• Function of Bruton’s Tyrosine Kinase during B Cell Development Is Partially Independent of Its Catalytic Activity 1

  2003influential reference
• Germline transcripts of immunoglobulin light chain variable regions are structurally diverse and differentially expressed.

  2003cited by this paper
• Impaired Precursor B Cell Differentiation in Bruton’s Tyrosine Kinase-Deficient Mice1

  2002influential reference
• Cooperation between IL-7 and the pre-B cell receptor: a key to B cell selection.

  2002cited by this paper
• Delayed Cellular Maturation and Decreased Immunoglobulin κ Light Chain Production In Immature B Lymphocytes Lacking B Cell Linker Protein

  2002cited by this paper
• The absence of SLP65 and Btk blocks B cell development at the preB cell receptor‐positive stage

  2001cited by this paper
• Bruton's Tyrosine Kinase Regulates the Activation of Gene Rearrangements at the λ Light Chain Locus in Precursor B Cells in the Mouse

  2001influential reference
• E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells.

  2000cited by this paper
• Repertoire selection by pre‐B‐cell receptors and B‐cell receptors, and genetic control of B‐cell development from immature to mature B cells

  2000cited by this paper
• B cell development and activation defects resulting in xid-like immunodeficiency in BLNK/SLP-65-deficient mice.

  2000cited by this paper
• Rearrangement and Expression of Immunoglobulin Light Chain Genes Can Precede Heavy Chain Expression during Normal B Cell Development in Mice

  1999cited by this paper
• Continued RAG expression in late stages of B cell development and no apparent re-induction after immunizion

  1999influential reference
• B cells are programmed to activate kappa and lambda for rearrangement at consecutive developmental stages.

  1999cited by this paper
• Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65.

  1999cited by this paper
• Early arrest in B cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region.

  1999influential reference
• Phosphatidylinositol 3-Kinase-dependent Membrane Association of the Bruton’s Tyrosine Kinase Pleckstrin Homology Domain Visualized in Single Living Cells*

  1999cited by this paper
• Induction of Ig light chain gene rearrangement in heavy chain-deficient B cells by activated Ras.

  1999cited by this paper
• B cells are programmed to activate κ and λ for rearrangement at consecutive developmental stages

  1999influential reference
• Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase

  1998cited by this paper
• Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B‐cell receptor activation

  1998cited by this paper
• Enforced Bcl-2 Expression Inhibits Antigen-mediated Clonal Elimination of Peripheral B Cells in an Antigen Dose–dependent Manner and Promotes Receptor Editing in Autoreactive, Immature B Cells

  1997cited by this paper
• EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes.

  1997cited by this paper
• Development of VH81X transgene-bearing B cells in fetus and adult: sites for expansion and deletion in conventional and CD5/B1 cells.

  1997influential reference
• The interleukin-1 receptor complex and interleukin-1 signal transduction.

  1997cited by this paper
• Re-evaluation of the probabilities for productive rearrangements on the κ andλloci

  1996cited by this paper
• Re-evaluation of the probabilities for productive arrangements on the kappa and lambda loci.

  1996cited by this paper
• Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre‐B cell stage.

  1996cited by this paper
• Regulation of Btk function by a major autophosphorylation site within the SH3 domain.

  1996cited by this paper
• Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain.

  1995cited by this paper
• Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice.

  1994cited by this paper
• The expression of Vpre-B/λ5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice

  1994cited by this paper
• Immature surface Ig+ B cells can continue to rearrange kappa and lambda L chain gene loci

  1993cited by this paper
• RAG-1-deficient mice have no mature B and T lymphocytes.

  1992influential reference
• Targeted disruption of µ chain membrane exon causes loss of heavy-chain allelic exclusion

  1992cited by this paper
• Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.

  1991cited by this paper
• Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription.

  1989cited by this paper

• Kidins220 regulates the development of B cells bearing the λ light chain

  2024influential citation
• Medicinal perspectives and Structure-activity relationship studies of Pyrimidine based Bruton’s tyrosine kinase inhibitors as potential anticancer agents

  2023cites this paper
• CD25: A potential tumor therapeutic target

  2022cites this paper
• IRF4 Has a Unique Role in Early B Cell Development and Acts Prior to CD21 Expression to Control Marginal Zone B Cell Numbers

  2021cites this paper
• Progress in the development of small molecular inhibitors of the Bruton's tyrosine kinase (BTK) as a promising cancer therapy.

  2021cites this paper
• Advances in covalent kinase inhibitors.

  2020cites this paper
• Novel Pyrimidines as Multitarget Protein Tyrosine Kinase Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

  2019cites this paper
• Foxo3 Promotes Apoptosis of B Cell Receptor–Stimulated Immature B Cells, Thus Limiting the Window for Receptor Editing

  2018cites this paper
• The emerging role of anti‐CD25 directed therapies as both immune modulators and targeted agents in cancer

  2017influential citation
• Ig light chain gene rearrangement pre-B cell differentiation and the induction of Bruton's tyrosine kinase and SLP-65 regulate

  2017cites this paper
• inhibiting caspase-8 processing and by oligodendrocytes from apoptotic cell death C5b-9 terminal complex protects

  2017cites this paper
• of autoimmune myasthenia T regulatory cells in the prevention + CD25 +of invariant NKT cells and CD4

  2017cites this paper
• Covalent binding design strategy: A prospective method for discovery of potent targeted anticancer agents.

  2017cites this paper
• Exploration of Novel Inhibitors for Bruton’s Tyrosine Kinase by 3D QSAR Modeling and Molecular Dynamics Simulation

  2016cites this paper
• Precursor B Cells Increase in the Lung during Airway Allergic Inflammation: A Role for B Cell-Activating Factor

  2016cites this paper
• Bruton's Tyrosine Kinase Deficiency Inhibits Autoimmune Arthritis in Mice but Fails to Block Immune Complex–Mediated Inflammatory Arthritis

  2016cites this paper
• BTK Signaling in B Cell Differentiation and Autoimmunity.

  2015cites this paper
• Dynamic Control of Long-Range Genomic Interactions at the Immunoglobulin κ Light-Chain Locus.

  2015influential citation
• Design, synthesis and evaluation of novel 5-phenylpyridin-2(1H)-one derivatives as potent reversible Bruton's tyrosine kinase inhibitors.

  2015cites this paper
• PU.1 Opposes IL-7–Dependent Proliferation of Developing B Cells with Involvement of the Direct Target Gene Bruton Tyrosine Kinase

  2015cites this paper
• Signaling circuits in early B-cell development.

  2014cites this paper
• Discovery of a Potent, Covalent BTK Inhibitor for B-Cell Lymphoma

  2014cites this paper
• Pre-B Cell Receptor Signaling Induces Immunoglobulin κ Locus Accessibility by Functional Redistribution of Enhancer-Mediated Chromatin Interactions

  2014influential citation
• B-ce LL precursor aBnormaL ities in chiL dhood acute LymphoBL astic Leukemia

  2014cites this paper
• Lymphophenia-Driven Proliferation and Stat6-Deficient CD4+ T Cells during Different Competitive Capacities of Stat4-

  2013cites this paper
• BLNK (B-cell linker)

  2013cites this paper
• Bruton's Tyrosine Kinase: Structure and Functions, Expression and

  2013cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology BLNK ( B-cell linker )

  2013cites this paper
• Studies on ITK-SYK signaling pathways

  2013cites this paper
• Endogenous Factors Causative of Spontaneous DNA Damage that Leads to Random Integration in Human Cells

  2013cites this paper
• Novel Mechanism of Tumor Suppression by Polarity Gene Discs Large 1 (DLG1) Revealed in a Murine Model of Pediatric B-ALL

  2013cites this paper
• Discovery of Novel Bruton’s Tyrosine Kinase Inhibitors Using a Hybrid Protocol of Virtual Screening Approaches Based on SVM Model, Pharmacophore and Molecular Docking

  2012cites this paper
• Altered BCR signalling quality predisposes to autoimmune disease and a pre‐diabetic state

  2012cites this paper
• Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man

  2011cites this paper
• Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunity

  2010cites this paper
• Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway.

  2010cites this paper
• Hematopoietic engraftment of XLA bone marrow CD34(+) cells in NOG/SCID mice.

  2009cites this paper
• PKC eta directs induction of IRF-4 expression and Ig kappa gene rearrangement in pre-BCR signaling pathway.

  2008cites this paper
• PKC h directs induction of IRF-4 expression and Ig k gene rearrangement in pre-BCR signaling pathway

  2008cites this paper
• Bruton's tyrosine kinase as a new therapeutic target.

  2007cites this paper
• C5b-9 Terminal Complex Protects Oligodendrocytes from Apoptotic Cell Death by Inhibiting Caspase-8 Processing and Up-Regulating FLIP1

  2005cites this paper
• Role of Pre-B Cell Receptor Signaling Molecules in B Cell Differentiation and Tumor Suppression

  2005cites this paper